GLP-1s Medications 101
GLP-1 medications are FDA-approved specifically for weight loss for more than half the adult population in the United States. Plan sponsors can take action to manage weight and other cardiodiabesity-r...
Read More
Clinically Speaking: Cardiodiabesity 101
More than half of U.S. adults suffer from cardiovascular disease, diabetes or obesity and a growing number experience all three. Plan sponsors can take action to address this increasingly complex chal...
Read More
Three of the biggest drivers of health care costs
Obesity, diabetes, and cardiovascular disease are on the rise. Left unmanaged, these comorbid conditions can cause medical expenses to skyrocket and lead to poor health outcomes, inclusive of disabili...
Read More
Awareness is key to combating the prevalence of heart disease in women
Cardiovascular disease is the leading cause of death for women in the United States, and studies show that awareness is a major issue.
Read More
Affordability, Cost Predictability Can Help Patients With Diabetes and Cardiovascular Disease Thrive
Budget-friendly copays encourage adherence, especially with expensive disease states.
Read More